小儿手术中术中美沙酮与其他阿片类药物的术后结局回顾性比较
这项单中心回顾性队列研究纳入1794例≤18岁接受6类手术的患儿,其中528例术中使用美沙酮。与使用其他阿片类药物相比,美沙酮组PACU最大疼痛评分更低、PACU阿片消耗更少、苏醒期谵妄发生率更低,纳洛酮使用、术后恶心呕吐和PACU停留时间无统计学差异。
要点
- 术中美沙酮与患儿PACU最大疼痛评分更低相关
- 术中美沙酮与患儿PACU阿片消耗减少相关
- 术中美沙酮与患儿苏醒期谵妄发生率更低相关
核心结论
- 在这项大型单中心回顾性研究中,小儿术中使用美沙酮与术后疼痛评分降低、阿片消耗减少及苏醒期谵妄减少相关。
- 纳洛酮使用、术后恶心呕吐和PACU停留时间在美沙酮组与其他阿片组间无统计学显著差异。
研究设计与样本
- 回顾性队列研究,纳入2018年1月1日至2024年2月29日接受6类手术的≤18岁患儿1794例,其中528例接受美沙酮。
- 主要结局为PACU最大疼痛评分,采用回归模型并控制手术类型、年龄、性别、ASA评分、BMI、术前/术中辅助用药数量及区域麻醉使用等变量。
临床怎么用
- 小儿特定手术中可考虑术中使用美沙酮,以降低PACU疼痛评分、阿片消耗和苏醒期谵妄。
- 仍需更大样本研究评估美沙酮与其他阿片类药物在小儿手术患者中的不良事件风险。
局限性
- 为单中心回顾性研究,可能存在残余混杂。
- 作者指出需要更大规模研究以获得足够效能评估不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Findings of randomized controlled trials indicate that intraoperative methadone administration reduces postoperative pain and opioid consumption compared to other opioids in many patient populations. While concerns about potential risks persist, large retrospective studies may be able to assess risks from methadone versus other opioids. Recent retrospective studies in adult patients found no association between methadone administration and adverse outcomes. Similar studies in pediatric patients are lacking. This retrospective study investigates the association of intraoperative methadone with postanesthesia care unit (PACU) pain scores and other relevant postoperative outcomes compared to other opioids. METHODS: We conducted a retrospective cohort study of pediatric patients (≤18 years of age) undergoing 1 of 6 surgeries from January 1, 2018 to February 29, 2024: spinal fusion for scoliosis, laparoscopic sleeve gastrectomy, bilateral mastectomy with nipple reconstruction, knee surgeries, Nuss repair for pectus excavatum, and cleft palate repair. The primary outcome was maximum PACU pain scores in patients receiving intraoperative methadone versus other opioids. Secondary outcomes were the incidence of moderate-severe PACU pain, opioid consumption, naloxone administration, emergence delirium, postoperative nausea and vomiting (PONV), and PACU length of stay (LOS). Results were analyzed using regression models, controlled for appropriate variables including procedure, age, sex, American Society of Anesthesiologists (ASA) score, body mass index (BMI), the number of pre/intraoperative adjuvants, and the use of regional anesthesia. Predefined subgroup analyses were conducted to compare patients who received methadone versus other opioids in the setting of (1) receiving preincision regional anesthesia; (2) receiving an intraoperative remifentanil infusion; and (3) in the methadone group, receiving a methadone dose ≥0.15 mg kg -1 . RESULTS: 1794 patients were included; 528 received methadone. Patients receiving methadone had a lower maximum PACU pain score (3.9 [95% confidence interval {CI}, 3.6-4.2] vs 4.5 [95% CI 4.3-4.6]; P = .007), decreased PACU opioid consumption (0.06 vs 0.09 MEU kg -1 ; P < .001), decreased emergence delirium (9.60% vs 16.90%; P < .001), and no statistically significant difference in naloxone administration, PONV, and PACU LOS compared to the other-opioid group. CONCLUSIONS: In this large, single-center retrospective study, intraoperative methadone administered to pediatric patients was found to be associated with reduced postoperative pain scores, opioid consumption, and emergence delirium. Larger studies are needed to achieve the necessary power to assess adverse events in pediatric surgical patients who receive methadone versus other opioids.
引用
- Pan SJ, De Souza E, Anderson TA, et al. Intraoperative Methadone Versus Other Opioids: A Retrospective Review of Postoperative Outcomes in Pediatric Surgeries. Anesth Analg. 2025. PMID: 40742896. doi:10.1213/ANE.0000000000007653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。